Strategic growth Diality is a private medical device company with a growing investor-backed capital base and a recent board expansion, signaling readiness for scaled partnerships and enterprising sales discussions with large healthcare providers, distributors, and care networks.

Product-market fit The Moda-flx Hemodialysis System combines in-center prescription capabilities with user-friendly, mobile, connected design, presenting strong cross-sell opportunities with dialysis clinics seeking flexible, modern solutions and workflow efficiency gains.

Adoption momentum Key recent hires in medical strategy and board-level appointments, along with active financing rounds, indicate accelerating market validation and potential for collaboration on clinical outcomes and population health initiatives.

Financial capacity With a revenue range in the tens of millions and total funding around eighty-three million, there is room for PKI-enabled pilots, financing partnerships, and value-based procurement discussions with hospital systems and specialty clinics.

Global partnerships Diality’s mobile, connected platform is well positioned for partnerships with distributors, medical device integrators, and health systems aiming to modernize kidney care, remote monitoring, and data connectivity across care settings.